Repeatable Battery for the Assessment of Neuropsychological Status Update

RBANS Update
  • Christopher Randolph
A brief individually administered battery to measure cognitive decline or improvement across five domains in ages 12 to 89 years 11 months
View all tests and materials
Prices include GST where applicable
RBANS Update Record Form A
0158007212 Qualification Level B

Pack of 25


AUD 245.08


Publication date:
Completion time:
30 minutes
Individual; Q-interactive administration and scoring; Q-global scoring and reporting; or manual scoring
Age range:
12 to 89 years 11 months
Qualification level:

Product Details

The RBANS Update provides a brief, individually administered battery to measure cognitive decline or improvement across 5 domains:

  • Immediate Memory – List learning and Story Memory
  • Visuospacial/Constructional – Figure Copy and Line Orientation
  • Language – Picture naming and Semantic Fluency
  • Attention – Digit Span and Coding
  • Delayed Memory – List Recall, List Recognition, Story Memory, and Figure Recall

This instrument is used by clinicians and neuropsychologists to help:

  • Screen for deficits in acute-care settings
  • Track recovery during rehabilitation
  • Track progression of neurological disorders
  • Screen for neurocognitive status in adolescents

RBANS Update now available on Q-interactive! Learn more.


Features & Benefits

RBANS Update provides significant improvements, including:

  • Downward age extension to 12:0 years
  • Subtest scores now available in addition to index scores
  • Manual updates, including information on adolescents and review of RBANS-specific research conducted since original publication(1998)

Parallel Forms

Ideal for measuring change over time, RBANS Update offers four parallel forms. Form A offers a single set of norms based on age, gender, race, education, and geographic region with equating studies and adjustments for Forms B-D.

RBANS Update can also be used in a variety of ways including:

  • As a stand-alone “core” battery for the detection and characterisation of dementia in the elderly
  • As a neuropsychological “screen battery” when lengthier assessments are either impractical or inappropriate
  • For repeat evaluations when an alternate form is needed to control for content practice effects
  • In Clinical Trials to identify inclusion/exclusion criteria as well as efficacy and cognitive side effects

Setting-Specific Information

Although RBANS Update was originally developed with a primary focuson assessment of dementia, special group studies are available for Alzheimer’s Disease, Vascular Dementia, HIV Dementia, Huntington’s Disease, Parkinson’s Disease, Depression, Schizophrenia, and Closed Head Injury. With the additional collection of adolescent data, RBANS Update also has utility as a screener for neurocognitive status in younger patients as well. Finally, RBANS UPDATE has been used in a number of Clinical Trials and is available in over 20 languages.